attexis is designed to offer therapeutic techniques and exercises based on evidence-based psychological-psychotherapeutic treatment methods, suitable for patients with ADHD (Attention Deficit Hyperactivity Disorder) to support them in managing their ADHD. attexis is for independent use by patients aged 18+. It is not intended to replace healthcare provider treatments or provide information for diagnostic or therapeutic decisions. Indications: Disturbance of activity and attention (F90.0), Hyperkinetic conduct disorder (F90.1).
Pricing
Paid
Manufacturer price €249.86 per prescription (90 days). DiGA directory: https://diga.bfarm.de/en/verzeichnis/02814
Category
Digital Therapeutics
Tags
—
Added
Sep 2026
Conditions (ICD-10)
Categories
Pros
- Permanently listed in the German BfArM DiGA directory
- Prescribable and reimbursed by German statutory health insurance
- Therapeutic area: Psychological